From the Frontline of COVID-19: Managing Drug Excipient Toxicities in the wake of COVID-19

In the wake of drug shortages, patients with a high requirement for sedation coupled with an increase in the number of patients who have renal failure due to complications to COVID-19, pharmacists must be ever vigilant on managing patient’s mediation regimens and monitoring for toxicities.  With that in mind, we sit down with our content matter experts to talk about managing patients who might be at risk for developing toxicities due to the excipients found in drugs and how pharmacists can play an important role in preventing these adverse events. 

 

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.